Jan 21
Episode 145: Myeloma Series, Pt. 6 - First line treatment of Multiple Myeloma (2026)
This week, we begin our discussion about treatment of multiple myeloma, focusing on the first-line setting. Once again, a lot has changed in this space over the last few years, most notably the standards of care (now quadruplet regimens instead of triplet regimens!). We break dow ... Show More
40m 27s
Jan 7
Episode 144: Myeloma Series, Pt. 5 - Myeloma Risk Stratification and Response Criteria (2026)
This week, we introduce a new episode for our myeloma series, this time focusing on risk stratification and response criteria. The initial workup and surveillance labs are expansive, but all of the studies we do have a purpose. Many present-day studies also use “minimal residual ... Show More
29m 16s
Dec 30
Episode 143: Myeloma Series, Pt. 4 - Myeloma Pharmacology (2025)
We bring back our prior pharmacology discussion because it’s so incredibly important for the conversations that are on the horizon over the next few weeks. In this continuation of our myeloma series, we begin our discussion about treatment options for multiple myeloma, focusing f ... Show More
48m 42s
Jan 2025
Episode 109: The Silent Crisis: Burnout in the Medical Field
<p>Listen to this latest episode of the podcast cohosted with MohammadAli Jardaly, with Dr. Alaa Rihan, a Family Medicine physician and a scholar, Leading Physician Wellbeing Program with the American Academy of Family Physicians. Burnout affects more than 50% of physicians in th ... Show More
29m 11s
Oct 21
211. Dr. Andy Galpin: On Recovery Modalities, Performance Anchors and Hidden Stressors
What if the solution to your health plateau isn’t adding more biohacks, but identifying the single hidden stressor that’s crushing everything else? Live from the Health Summit stage, Dr. Andy Galpin introduces the concepts of “performance anchors” and the “three I’s framework,” t ... Show More
1 h
Jun 2020
Covid-19 update: Cardiovascular disease, testing, social distancing and shielding, and dexamethasone
Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to covid-19. Emma Scott discusses the latest guidance on cardiovascular disease. And Matt Castleden updates us on NHS Test and Trace, shi ... Show More
11m 12s
In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.
Episode contents:
- How do we assess fitness for intensive AML?
- What are options for patients who are unfit for intensive chemotherapy for AML?
- What are important genetic mutations are important to check for?
- What are the key trials that inf ... Show More
<p>Consultant Rheumatologist and co-host of the <a href="https://rcpsg.ac.uk/physicians/membership/the-medical-take" rel="noopener noreferrer" target="_blank">Medical Take podcast</a>, <a href="https://twitter.com/helloarrianne" rel="noopener noreferrer" target="_blank">Dr Arrian ... Show More
